PDF Archive search engine
Last database update: 06 May at 08:40 - Around 76000 files indexed.
www.openmedscience.com Review Article 68 Ga-Somatostatin Tumors Analogue PET/CT in Neuroendocrine Elisabetta Giovannini*, Maria Chiara Gaeta, Andrea Ciarmiello Nuclear Medicine Unit, Sant’Andrea Hospital, La Spezia, Italy *Author to whom correspondence should be addressed:
It has demonstrated utility in the differential diagnosis between these primary tumors and corresponding metastatic renal cell carcinoma within the context of an antibody panel.
Houston, USA 14:15 - 15:00 Aggressive tumors of the skin appendages:
By Emily Oster Filed under Women's Health A Canadian study published in February reignited the years-long debate over breast cancer screening methods, arguing fairly strongly against mammography, or the use of X-rays to detect tumors.
Women with ER-positive breast tumors have a better prognosis than women with ER-negative tumors in terms of responsiveness to anti-estrogen treatment.
A MULTIANALYTE ALGORITHM PCR-BASED BLOOD TEST OUTPERFORMS SINGLE ANALYTE ELISA-BASED BLOOD TESTS FOR NEUROENDOCRINE TUMOR DETECTION A key issue in management of neuroendocrine tumors (NETs) is specific and sensitive biomarkers.
Because of the excellent outcome of DTC and the potential cancerous effect of iodine-131, in the last years there has been a huge number of articles addressing the issue of the incidence of second tumors in DTC patients.
Tumors appear most frequently on sun-exposed surfaces of the body (Sarma et al.
Lung Cancers 2009 - 2010 Member, Scientific Review Committee, AACR Frontiers in Cancer Prevention Research Conference 2009 Member, American Institute of Biological Sciences “Molecular Signatures of Tumors Panel B” Peer Review Panel, U.S.
There is heterogeneity with respect to the autonomous invasive traits of epithelial-like breast cancer populations derived from different patient tumors (9, 10).
Classification, epidemiology, clinical presentation, localization, and staging of pancreatic neuroendocrine tumors.
The requirements of the first oncological disease—gastrointestinal tumors—were defined as late as 2014.
3.35 – 4.05 PM The MILAN system and molecular approach to cytologic diagnosis of salivary gland tumors Frontiers in molecular cytopathology 4.10 – 5.00 PM Potpourri of challenging cases in cytology 5.00 PM onwards Dr.